Newly identified PET biomarker predicts success of immune checkpoint blockade therapy
The protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment.
May 14, 2024
0
43
